Literature DB >> 18615130

Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Javier González-Maeso1, J Javier Meana.   

Abstract

Mood disorders such as major depression and bipolar disorder are common, severe, chronic and often life-threatening illnesses. Suicide is estimated to be the cause of death in up to approximately 10-15% of individuals with mood disorders. Alterations in the signal transduction through G protein-coupled receptor (GPCR) pathways have been reported in the etiopathology of mood disorders and the suicidal behavior. In this regard, the implication of certain GPCR subtypes such as alpha(2A)-adrenoceptor has been repeatedly described using different approaches. However, several discrepancies have been recently reported in density and functional status of the heterotrimeric G proteins both in major depression and bipolar disorder. A compilation of the most relevant research topics about the implication of heterotrimeric G proteins in the etiology of mood disorders (i.e., animal models of mood disorders, studies in peripheral tissue of depressive patients, and studies in postmortem human brain of suicide victims with mood disorders) will provide a broad perspective of this potential therapeutic target field. Proposed causes of the discrepancies reported at the level of G proteins in postmortem human brain of suicide victims will be discussed.

Entities:  

Keywords:  G protein-coupled receptors (GPCR); Mood disorders; bipolar disorder; heterotrimeric G proteins; major depression; suicide; α2-adrenoceptors

Year:  2006        PMID: 18615130      PMCID: PMC2430671          DOI: 10.2174/157015906776359586

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  178 in total

1.  The superfamily of heptahelical receptors.

Authors:  R J Lefkowitz
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

Review 2.  International Union of Pharmacology. XLVI. G protein-coupled receptor list.

Authors:  Steven M Foord; Tom I Bonner; Richard R Neubig; Edward M Rosser; Jean-Phillipe Pin; Anthony P Davenport; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

3.  The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy.

Authors:  J M Weiss; P H Morgan; M W Lutz; T P Kenakin
Journal:  J Theor Biol       Date:  1996-08-21       Impact factor: 2.691

4.  Analysis of polymorphisms in the olfactory G-protein Golf in major depression.

Authors:  Peter Zill; Rolf Engel; Thomas C Baghai; Peter Zwanzger; Cornelius Schüle; Christo Minov; Stefanie Behrens; Rainer Rupprecht; Hans Jürgen Möller; Brigitta Bondy
Journal:  Psychiatr Genet       Date:  2002-03       Impact factor: 2.458

5.  Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

Authors:  G Milligan; R A Bond; M Lee
Journal:  Trends Pharmacol Sci       Date:  1995-01       Impact factor: 14.819

6.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin.

Authors:  J Nathans; D S Hogness
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

7.  Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder.

Authors:  R Mathews; P P Li; L T Young; S J Kish; J J Warsh
Journal:  Biol Psychiatry       Date:  1997-03-15       Impact factor: 13.382

8.  Carbamazepine and electroconvulsive shock attenuate beta-adrenoceptor and muscarinic cholinoceptor coupling to G proteins in rat cortex.

Authors:  S Avissar; G Schreiber; C S Aulakh; K M Wozniak; D L Murphy
Journal:  Eur J Pharmacol       Date:  1990-07-31       Impact factor: 4.432

9.  Brain noradrenergic receptors in major depression and schizophrenia.

Authors:  V Klimek; G Rajkowska; S N Luker; G Dilley; H Y Meltzer; J C Overholser; C A Stockmeier; G A Ordway
Journal:  Neuropsychopharmacology       Date:  1999-07       Impact factor: 7.853

Review 10.  From monoamines to genomic targets: a paradigm shift for drug discovery in depression.

Authors:  Ma-Li Wong; Julio Licinio
Journal:  Nat Rev Drug Discov       Date:  2004-02       Impact factor: 84.694

View more
  8 in total

Review 1.  Theoretical considerations on the topological organization of receptor mosaics.

Authors:  Agnati Luigi Francesco; Fuxe Kjell; Woods Amina; Genedani Susanna; Guidolin Diego
Journal:  Curr Protein Pept Sci       Date:  2009-12       Impact factor: 3.272

2.  Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders.

Authors:  Susana Mato; Fuencisla Pilar-Cuéllar; Elsa M Valdizán; Javier González-Maeso; Rafael Rodríguez-Puertas; Javier Meana; Joan Sallés; Benedicto Crespo-Facorro; Ángel Pazos
Journal:  Biochem Pharmacol       Date:  2018-08-10       Impact factor: 5.858

3.  Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.

Authors:  Madhurima Benekareddy; Nathalie M Goodfellow; Evelyn K Lambe; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

Review 4.  α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy.

Authors:  Christopher Cottingham; Qin Wang
Journal:  Neurosci Biobehav Rev       Date:  2012-08-13       Impact factor: 8.989

5.  Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress.

Authors:  Madhurima Benekareddy; Krishna C Vadodaria; Amrita R Nair; Vidita A Vaidya
Journal:  Biol Psychiatry       Date:  2011-09-28       Impact factor: 13.382

6.  Identification and evaluation of network modules for the prognosis of basal-like breast cancer.

Authors:  Robin M Hallett; Jessica G Cockburn; Brian Li; Anna Dvorkin-Gheva; John A Hassell; Anita Bane
Journal:  Oncotarget       Date:  2015-07-10

7.  Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder.

Authors:  Abraham Nunes; William Stone; Raffaella Ardau; Anne Berghöfer; Alberto Bocchetta; Caterina Chillotti; Valeria Deiana; Franziska Degenhardt; Andreas J Forstner; Julie S Garnham; Eva Grof; Tomas Hajek; Mirko Manchia; Manuel Mattheisen; Francis McMahon; Bruno Müller-Oerlinghausen; Markus M Nöthen; Marco Pinna; Claudia Pisanu; Claire O'Donovan; Marcella D C Rietschel; Guy Rouleau; Thomas Schulze; Giovanni Severino; Claire M Slaney; Alessio Squassina; Aleksandra Suwalska; Gustavo Turecki; Rudolf Uher; Petr Zvolsky; Pablo Cervantes; Maria Del Zompo; Paul Grof; Janusz Rybakowski; Leonardo Tondo; Thomas Trappenberg; Martin Alda
Journal:  Transl Psychiatry       Date:  2021-01-11       Impact factor: 6.222

8.  Gene expression profiles underlying aggressive behavior in the prefrontal cortex of cattle.

Authors:  Paulina G Eusebi; Natalia Sevane; Thomas O'Rourke; Manuel Pizarro; Cedric Boeckx; Susana Dunner
Journal:  BMC Genomics       Date:  2021-04-07       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.